Shengtai Pharmaceutical, Inc. Announces Earnings Conference Call

WEIFANG, Shandong, China, Feb. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, and a manufacturer and distributor in China of starch products, will hold a conference call to discuss its 2^nd quarter fiscal year 2011 earnings.

Conference Call

The Company will host a conference call on Tuesday, February 15, 2011 at 7:00 P.M. Eastern Standard Time. A question and answer session will follow management's presentation.  Mr. Qingtai Liu (Chief Executive Officer), Mr. Yongqiang Wang (Chief Financial Officer), Mr. Weijie Liu (Vice President), and Ms. Yukie Gao Ying (Investor Relations Manager) will be the primary speakers on the call.

To participate, please call the following numbers ten minutes before the call start time:

Phone Number + 1 [phone] (North America)
Phone Number + 1 [phone] (International)

A replay of the call will be available through Wednesday, February 23, 2011, at 11:59 P.M. Eastern Standard Time. For the replay, please call:

Phone Number [phone] (North America)
Phone Number [phone] (International)
Account Number: 286
Conference ID Number: 367449

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary, Shengtai Holding, Inc. (SHI), and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a manufacturer and distributor in China of glucose and starch products as pharmaceutical raw materials, other starch products and other glucose products such as corn meals, food and beverage glucose. For more information about Shengtai Pharmaceutical, Inc., please visit www.shengtaipharmaceutical.com .

For more information, please contact:
Shengtai Pharmaceutical, Inc. Ms. Yukie Ying Gao Investor Relations Manager Tel:   [phone] Email: [e-mail]
Investor Relations DME Capital LLC David Elias Tel:   [phone] Email: [e-mail]

SOURCE Shengtai Pharmaceutical, Inc.

Copyright 2011 PR Newswire